Filing Details
- Accession Number:
- 0001474506-20-000294
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-11-04 16:53:14
- Reporting Period:
- 2020-11-02
- Accepted Time:
- 2020-11-04 16:53:14
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1267602 | Alimera Sciences Inc | ALIM | Pharmaceutical Preparations (2834) | 200028718 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1374256 | Jr S Richard Eiswirth | 6120 Windward Parkway Ste 290 Alpharetta GA 30005 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-11-02 | 2,500 | $4.15 | 42,043 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- The sales price reported is a weighted average price of multiple sales in a range of sale prices between $4.11 per share and $4.175 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within this range.